Table 2

Two logistic regression analyses with the outcome filaggrin null mutation status and diabetes, respectively, and adjusted for variables shown in the table as well as age

Explanatory variablesGeneral population, patients with type 1 and 2 diabetes (n=4213)
Filaggrin null mutation
Percentage (n/ntotal)Adjusted OR* with 95% CI
Sex
 Men7.8 (159/2029)1 (reference)
 Women8.8 (193/2184)1.18 (0.94 to 1.47)
Group
 Non-diabetic7.8 (246/3136)1 (reference)
 Screen-detected diabetes9.1 (6/66)1.23 (0.52 to 2.88)
 Self-reported diabetes12.8 (17/133)1.78 (1.05 to 3.04), p=0.032
 Type 1 diabetes6.7 (7/104)0.86 (0.39 to 1.87)
 Type 2 diabetes9.8 (76/774)1.37 (1.003 to 1.89), p=0.048
General population and patients with type 2 diabetes (n=4109)
Explanatory variablesDiabetes
Percentage (n/ntotal)Adjusted OR* with 95% CI
Sex
 Men29.8 (586/1967)1 (reference)
 Women18.1 (387/2142)0.56 (0.46 to 0.67), p=0.001
Filaggrin
 Wild type23.2 (874/3764)1 (reference)
 Null mutation28.2 (99/345)1.50 (1.10 to 2.06), p=0.011
BMI (kg/m2)
 <259.7 (167/1713)1 (reference)
 25–3023.2 (341/1469)1.97 (1.56 to 2.47), p=0.001
 >3049.1 (461/905)7.36 (5.79 to 9.36), p=0.001
  • Non-diabetic, healthy controls from the general population in Copenhagen; Screen-detected diabetes, diabetes screening group defined as subjects who did not report diabetes but who had a fasting blood glucose ≥7 and/or glycated haemoglobin ≥6.5%. Self-reported diabetes, diabetes group defined as subjects who gave an affirmative answer to the question: ‘Have you ever been told that you suffered from diabetes?’

  • * Mutually adjusted for variables shown in the table and age.

  • Diabetes was defined as belonging to the ‘screen-detected diabetes group,’ the ‘self-reported diabetes group,’ or the ‘type 2 diabetes group.’ The ‘type 1 diabetes groups’ was regarded as missing data.

  • Statistically significant.